Global Health Impact suggests that everyone should have access to medicine | DocMode
Global Health Impact suggests that everyone should have access to medicine

Every human has a right to take care of his/her health and therefore should be given proper access and rights to essential medicines. But sadly, there aren’t enough policies to let us avail to these rights. To address this issue Nicole Hassoun, professor of philosophy at Binghamton University, New York appealed about the new initiatives that should be taken to encourage pharmaceutical companies to ensure that everyone has access to essential medicine in her new book “Global Health Impact: Extending Access to Essential Medicines.

In her book, Hassoun suggests some new labeling, investment and licensing approaches for the Global Health Impact that will enable pharmaceutical companies to strengthen global public health. Hassoun presented the idea to rate pharma companies based on the impacts of their medicines. Highly rated businesses will be given a mark for Global Health Impact to use on their products. Socially responsible investment companies and universities could also take the scores into consideration when making investment or licensing decisions. 

The book has three sections The first part especially advocates a human right to health and access to basic medicines. This defends the case against recent criticism of those rights being proposed. The second element introduces the idea for a Global Health Impact and develops it. The final section calls for consuming products with Global Health Impact and similar ethical marks, and discusses what kind of scientific proof the plan supports.

Hassoun has been working for the Global Health Impact Index to use data to improve public health. The index looks at three things: the need for a variety of essential tuberculosis medicines, HIV / AIDS , malaria and various neglected tropical diseases; the efficacy of the medicines; and the number of people who can access such drugs. The score of each enterprise is the sum of the impacts of its products. It was initially launched in 2015 at the World Health Organization in Geneva. For companies who can mark their products with a Fair Trade logo, Hassoun hopes they will be motivated by a similar ranking system for pharmaceutical companies to change their policies and make their products more widely available.

Tag Cloud

Follow us on Facebook

Follow us on Twitter